Moreover, whereas treatment with TGFβ1 had little impact on ID2 expression in either mouse mammary carcinoma or human breast cancer cells, BMP7 treatment resulted in a > 50-fold increase in ID2 mRNA levels and this level of expression was sustained for at least 5 days following BMP7 withdrawal. The gene discussed is ID2; the disease is breast cancer.